Biography

Xxx Xxxx Xxxxxxxxx XX is a physician-scientist with 35+ years of international executive leadership and management experience overseeing commercial oncology (including immunotherapies), pharmaceutical research and development (Phase I-III), drug discovery, preclinical translational and clinical medicine, clinical pharmacology, and commercial development strategy and risk management. Xx xx xxx inventor/co-inventor on more than 400 issued United States and international pharmaceutical patents and author/co-author of more than 200 scientific/medical publications. Xxx Xxxxxxxx has provided expert input and/or overseen research and development of monoclonal antibodies, BiTES, ADCs, bispecific antibodies, protein-drug conjugates, bone marrow transplantation, CAR T therapies, and immunomodulators as well as agents that modulate the tumor microenvironment. Xxx Xxxxxxxx has provided written expert opinions, depositions, and testimony on several major high-stakes litigation (US Federal Court, US and Swiss International Courts of Arbitration, and other jurisdictions) cases involving pharmaceutical development for cancer treatments. Xx xx xxxxxxx xx Xxxxxxx Xxxxx.